BREAKING NEWS: Biolex and Merial Broaden Collaboration Innovative Vaccines from a Novel Antigen Expression and Manufacturing Platform
Biolex Announces Presentation at EASL of Interim Results from 480 Study, a Phase 2b Trial of Locteron® in Chronic Hepatitis C
Biolex Announces Presentation at EASL of Interim Results from EMPOWER Phase 2b Study of Locteron® in Chronic Hepatitis C
